US Broker Ratings

Pacific Biosciences of California (PACB) Stock Analysis: Exploring a Potential 43% Upside

Pacific Biosciences of California, Inc. (NASDAQ: PACB) is making waves in the healthcare sector with its cutting-edge sequencing solutions, capturing the attention of investors seeking a blend of innovation and..

UroGen Pharma Ltd. (URGN) Stock Analysis: Unpacking the 94.75% Potential Upside

For investors eyeing the biotechnology landscape, UroGen Pharma Ltd. (NASDAQ: URGN) presents a compelling opportunity. With a market capitalization of $801.76 million, this healthcare company is making strides in the..

TotalEnergies SE (TTE) Stock Analysis: Uncovering a 16.42% Upside Potential for Investors

TotalEnergies SE (TTE) is making waves in the energy sector with a compelling investment narrative that holds promise for both stability and growth. As the integrated oil and gas giant..

Viant Technology Inc. (DSP) Stock Analysis: Exploring a 116% Potential Upside with Strong Buy Ratings

Viant Technology Inc. (NASDAQ: DSP) is drawing significant attention from investors, not only for its innovative role in the advertising technology space but also for its substantial upside potential. With..

Alumis Inc. (ALMS) Investor Outlook: Exploring a 328.89% Potential Upside in the Biotech Sector

Alumis Inc. (NASDAQ: ALMS), a dynamic player in the biotechnology sector, has captured the attention of investors with its promising pipeline focused on autoimmune disorders. Based in South San Francisco,..

Tvardi Therapeutics, Inc. (TVRD): Investor Outlook Highlights Robust 43% Upside Potential

Individual investors with a keen eye for opportunities in the biotechnology sector may find Tvardi Therapeutics, Inc. (NASDAQ: TVRD) an intriguing pick, given its substantial upside potential. With a promising..

Erasca, Inc. (ERAS) Stock Analysis: Unlocking an 88% Potential Upside in the Biotech Sector

Erasca, Inc. (NASDAQ: ERAS) is capturing the interest of investors with its strategic focus on precision oncology and a potential upside of 88.12%, as indicated by analyst ratings. The company’s..

Neuronetics, Inc. (STIM) Stock Report: Healthcare Innovator with 118.86% Potential Upside

Neuronetics, Inc. (NASDAQ: STIM), a prominent player in the healthcare sector, is drawing significant attention from investors eager to capitalize on potential upside opportunities. With a market capitalization of $196.39..

Sanara MedTech Inc. (SMTI): Investor Outlook Reveals 54% Potential Upside in Healthcare Innovator

Sanara MedTech Inc. (NASDAQ: SMTI), a dynamic player in the healthcare sector, is capturing the attention of individual investors with its promising growth potential. Based in Fort Worth, Texas, Sanara..

Anbio Biotechnology (NNNN) Stock Report: Navigating a Tumultuous Year Amidst a 52-Week Price Fluctuation

Anbio Biotechnology, trading under the symbol NNNN, has captured the attention of investors with its impressive 52-week price range and innovative product line. Based in Frankfurt am Main, Germany, this..

Aura Biosciences, Inc. (AURA): Biotechnology Stock with 248% Upside Potential Draws Investor Attention

Aura Biosciences, Inc. (NASDAQ: AURA), a clinical-stage biotechnology company based in Boston, Massachusetts, is capturing investor interest with its innovative approach to treating solid tumors. The company’s proprietary platform leverages..

Nyxoah SA (NYXH) Stock Analysis: A Compelling Investment with 108% Potential Upside

Nyxoah SA (NASDAQ: NYXH) presents a fascinating opportunity for investors looking to capitalize on the burgeoning healthcare sector, specifically within the medical instruments and supplies industry. Based in Belgium, Nyxoah..

Quantum-Si Incorporated (QSI) Stock Analysis: Exploring a 50% Upside in the Innovative Medical Device Sector

Quantum-Si Incorporated (NASDAQ: QSI) is making waves in the healthcare sector with its cutting-edge advancements in medical devices, particularly through its focus on Next Generation Protein Sequencing (NGPS). Headquartered in..

Chevron Corporation (CVX) Investor Outlook: Assessing Potential Upside Amidst Robust Dividends

Chevron Corporation (NYSE: CVX) stands as a formidable player in the energy sector, boasting a market capitalization of $309.76 billion. Despite a recent slight dip in its stock price by..

ClearPoint Neuro Inc. (CLPT) Stock Analysis: Exploring Growth in the Medical Devices Sector

ClearPoint Neuro Inc. (CLPT), a pioneering name in the healthcare sector, is making waves with its innovative approach to minimally invasive brain surgery. Headquartered in Solana Beach, California, ClearPoint Neuro..

Abeona Therapeutics Inc. (ABEO) Stock Analysis: A Compelling 270% Upside Potential in Biotech

Abeona Therapeutics Inc. (NASDAQ: ABEO), a cutting-edge player in the biotechnology sector, is capturing investor attention with its promising pipeline and remarkable upside potential. This Cleveland-based clinical-stage biopharmaceutical company specializes..

Phathom Pharmaceuticals (PHAT) Stock Analysis: Exploring Nearly 93% Potential Upside

Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT), a biopharmaceutical company specializing in gastrointestinal treatments, has caught the attention of the investment community due to its significant growth potential and promising pipeline. With..

aTyr Pharma, Inc. (ATYR) Stock Analysis: Exploring the 300% Potential Upside

Investors are always on the lookout for opportunities that present significant potential returns, and aTyr Pharma, Inc. (NASDAQ: ATYR) is currently drawing attention with its staggering 300% potential upside. As..

CytomX Therapeutics, Inc. (CTMX) Stock Analysis: Unraveling its 71.68% Potential Upside

CytomX Therapeutics, Inc. (NASDAQ: CTMX), a pioneering entity in the biotechnology landscape, is capturing the attention of investors with its innovative approach to cancer treatment. Specializing in conditionally activated biologics,..

XOMA Royalty Corporation (XOMA) Stock Analysis: Exploring a Potential 91.66% Upside

XOMA Royalty Corporation (NASDAQ: XOMA), a key player in the biotechnology sector, is capturing investor interest with its unique business model and promising financial outlook. Headquartered in Emeryville, California, XOMA..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds